Lipid variability and risk of microvascular complications in patients with diabetes: a systematic review and meta-analysis.

Authors:
Karimi MA; Vaezi A; Ansari A; Archin I; Dadgar K and 12 more

Journal:
BMC Endocr Disord

Publication Year: 2024

DOI:
10.1186/s12902-023-01526-9

PMCID:
PMC10759662

PMID:
38167035

View on PubMed View on PMC View Publisher
Journal Information

Full Title: BMC Endocr Disord

Abbreviation: BMC Endocr Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel.
Lertsakulbunlue S; Sangkool T; Bhuriveth V and 4 more (2024) - Transparency Score: 3/6
Clinical application of combination [<sup>11</sup>C]C-methionine and [<sup>13</sup>N]N-ammonia PET/…
Wang Z; Feng Z; Zhu D and 4 more (2024) - Transparency Score: 3/6
Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.
Fang Y; Mei W; Wang C and 8 more (2024) - Transparency Score: 3/6
Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer.
Zhuang Y; Cai Q; Hu X and 1 more (2024) - Transparency Score: 3/6
Fear of hypoglycemia and illness perception in type II diabetes patients.
Fariba A; Amerzadeh M; Banazadeh M and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025